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Why disease due to Mycobacterium tuberculosis is less 
common than expected in HIV-positive patients in 
Edinburgh 
A. G. LEITCH*§, M. RUBILAR*, B. WATT?, R. LAING$, L. WILLCOCKS$, R. P. BRETTLE~ AND 
C. L. S. LEEN$ 
Respiratory Medicine* and Infectious Diseasest Units, Department of Medicine (RIE), University oj’ 
Edinburgh and Scottish Mycobacteria Reference Laboratory?, City Hospital, Edinburgh, U.K. 
By December 1993, only five cases of tuberculosis were observed in the 1030 HIV-positive patients in 
Edinburgh, U.K., although, on the basis of historical tuberculin skin test data, between four and eight new 
cases of tuberculosis were expected per year. Of 310 HIV-positive patients, none of the 19 (6.1%) who were 
tuberculin skin test positive had developed tuberculosis after 87 months (average) of follow-up. It is suggested 
that new or re-infection is a more common cause of tuberculosis in HIV-positive patients than reactivation. 
Restriction fragment length polymorphism typing of Mycobacterium tuberculosis strains could confirm this 
hypothesis and support currently suggested additional infection control procedures. 
Introduction 
Edinburgh has recently experienced an epidemic of 
HIV infection (1). By December 1993, 1030 cases of 
HIV infection had been notified, with 60% of these 
among intravenous drug abusers (2). Only five cases 
of tuberculosis (TB) complicating HIV infection had 
been reported in these 1030 cases up to December 
1993, in comparison with rates of TB infection in 
AIDS cases in Europe ranging from 4.7% in Italy to 
46% in Portugal (3). In the only study performed to 
date, tuberculosis is reported to complicate HIV 
infection in those dually infected with Mycobacterium 
tuberculosis and HIV at the rate of 10% per annum 
(4). Therefore, this study seeks (1) to determine the 
outcome in HIV-positive patients known to have 
been tuberculin skin test positive when tested at the 
age of 13 years as part of the schools BCG vaccina- 
tion programme and (2) on the basis of similar 
historical skin test data appropriate to the age groups 
of the HIV-positive patients, to predict the total 
number of cases of tuberculosis expected per annum 
in this population. The clinical features of the five 
cases of tuberculosis are also described. 
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Methods 
Chest clinic records of skin test and BCG vacci- 
nation status were checked for matches of name 
and date of birth for the 523 HIV-positive patients 
identified in Edinburgh by 1991. Lothian Health 
Board records for the birth cohorts of the years 1969, 
1974 and 1979 were checked for the number of 
natural tuberculin skin test positive reactors deter- 
mined for each cohort at the age of 13 years during 
the schools BCG programme. 
Results 
TUBERCULIN POSITIVITY IN HIV-POSITIVE PATIENTS 
Three hundred and ten of 523 HIV-positive 
patients had matches of name and date of birth on 
the check of school skin test and BCG vaccination 
records. Of these 310 patients, 243 had Heaf skin 
tests grade 0 or 1 and had received BCG; 46 patients 
had defaulted (of whom, interestingly, 43 became 
intravenous drug users); four patients had not been 
given BCG for various reasons, one had calcified 
primary TB on the chest radiograph and one had 
previously treated TB; and 17 patients had not been 
given BCG because they were natural positive 
reactors, i.e. Heaf tests grade 24 without previous 
BCG. Therefore, there were 19 individuals with pre- 
vious tuberculous infection (one previously treated) 
identified by skin testing or chest radiography who 
0 1995 W. B. Saunders Company Ltd 
496 A. G. Leitch et al. 
were subsequently found to be HIV-positive. After 
post-HIV diagnosis follow-up for 87 months on 
average (range 24-123 months), none of these 
patients had developed TB although, on the basis of 
a rate of 10% TB yr - ’ in the dually infected, 1.8 
cases per annum (13 cases over the average 7-yr 
period of follow-up) would have been expected (4). 
The most recent CD, counts for these 19 individuals 
show that four patients had counts of ~500 mm- 3, 
seven patients had counts of 500-1000 mm - 3 and 
eight patients had counts of > 1000 mm ~ 3. 
PREDICTIONS OF DUAL INFECTION BASED ON 
HISTORICAL SKIN TEST DATA 
In 1993, the mean age of the HIV-positive popu- 
lation was 33.9 ZL 7.4 (SD) years. The majority of this 
population was included in this study after consider- 
ation of the tuberculin skin test status at the age of 13 
years of the birth cohorts of 1969, 1974 and 1979, 
when the percentage of natural tuberculin skin test 
positive reactors (Heaf test grades 24 without previ- 
ous BCG) ranged from 4.2-7.7%. Assuming that 
these figures apply to those subsequently becoming 
HIV-positive, then 48 cases of TB yr - ’ would be 
expected from the 1993 population of lOOO+ HIV- 
positive patients and 24 cases yr - ’ from the 500+ 
HIV-positive patients who had been identified by 
1991 on the basis of a rate of 10% TB yr - ’ in the 
dually infected (4). These expected figures compare 
with the observation of a cumulative total of only 
five cases of tuberculosis in the HIV-positive 
population. 
THE FIVE CASES OF TUBERCULOSIS 
Five male, HIV-positive patients aged 25-29 years 
presented between 1988-1993 with fevers, sweating 
and malaise without new respiratory symptoms and 
were found to have TB. Four patients were intra- 
venous drug users and one was homosexual. Chest 
radiography was normal in three of these patients, 
showed a pleural effusion in one patient and showed 
basal lung shadowing in the other. One patient had 
one sputum specimen which was smear positive for 
M tuberculosis; three patients were sputum culture 
positive and the organism was isolated from the 
blood or marrow in four cases, from urine in two 
cases, from lymphatic tissue in two cases and from 
pleural fluid in one patient. The organisms were fully 
sensitive and a good response was seen to rifampicin, 
isoniazid, pyrazinamide and ethambutol for 2 
months, followed by triple therapy with rifampicin, 
isoniazid and ethambutol for a total of 18 months. 
Two patients had had documented BCG confirmed 
by the presence of a scar; three patients had no 
history of BCG and no scar. The CD, count was over 
100 mm - 3 (range 100-200) in four patients and 
10 111111~~ in the fifth. 
Discussion 
Edinburgh (population about 0.6 x 106) has 
experienced a fall in TB notifications from 182 yr - ’ 
in 1980 to 56 yr -’ in 1993 of which only 26% had 
smear positive pulmonary, and therefore infectious, 
disease (5). The low number of infectious cases of TB, 
combined with continuing stringent public health 
measures of TB control (6) renders the likelihood of 
transmission of TB, even to the immunocompro- 
mised, very low. 
Tuberculosis developing in the HIV-positive 
patients would therefore be expected to be 
more commonly due to reactivation of pre-existing 
tuberculous infection. 
The mean age of the Edinburgh HIV-positive 
population is relatively low at 33.9 f 7.4 (SD) years, 
and the rate of pre-existing tuberculous infection 
determined by consulting historical skin test records 
from the schools BCG vaccination programme is 
therefore also low at between 48%. Even with this 
low rate of pre-existing TB infection, and therefore 
dual infection in the HIV-positive patients, the 
observed number of TB cases in the HIV population 
of this study is much lower than would be expected 
from the observed rate of development of TB of 
lO%yr-’ in dually infected patients in North 
America (4). If the North American cases were due, 
as claimed, to reactivation disease and the same rate 
of reactivation applied to the dually infected HIV 
population in Edinburgh, then between 48 cases of 
TB yr-’ would have resulted rather than the 
observed total of five cases of TB. The absence of 
tuberculous disease in the 18 known tuberculin posi- 
tive HIV patients (followed up on average for 7 yr) 
supports this hypothesis although it is possible that 
TB may yet develop in individuals in this group. 
This leads to the suggestion that the 10% yr - ’ rate 
of development of TB in the North American report 
on dual infection (4) does not represent, as claimed, 
development of TB due to reactivation. Instead, it is 
suggested that TB developing in the dually infected is 
more often due to new or re-infection with TB as has 
been well described recently in homeless men in 
Australia (7) and in patients with advanced HIV- 
infection in North America (8). Such re-infection 
would be unlikely to occur in a low-prevalence area 
like Edinburgh. 
The hypothesis that TB in the HIV infected is 
more likely to be due to re-infection rather than 
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reactivation as is currently believed, is amenable to 
testing in dually infected HIV-positive populations 
by the application of currently available Restriction 
fragment length polymorphism techniques of typing 
M. tuberculosis (9). Support from such testing for the 
re-infection hypothesis would lend added weight to 
the additional control measures currently being pro- 
posed in relation to TB in HIV-positive patients (10). 
Acknowledgements 
We are grateful to Dr S. Findlay for assistance 
with school medical service skin test data, to col- 
leagues in the IUATLD for helpful discussions and 
to Miss J. Holywell for typing this manuscript. 
References 
European Workshop on Tuberculosis Control in 
Low Prevalence Countries, Woltheze, The Netherlands. 
20 March 1994. 
4. Selwyn PA, Sckell BM, Alcabes P et al. High risk of 
active tuberculosis among HIV-infected drug users with 
cutaneous anergy. JAMA 1992: 268: 504-509. 
5. Leitch AG. Annual Reports of Tuberculosis Not$cations 
in Edinburgh. 
6. Brochwicz-Lewinski MJ, Rubilar M, Anderson M, 
Leitch AG. The outcome of contact procedures for 
tuberculosis in Edinburgh, Scotland 1982-1991. Am 
Rev Respir Dis 1994; 149: A704. 
7. Dwyer B, Jackson K, Raios K, Sievers A, Wiltshire E, 
Ross B. DNA restriction fragment analysis to define an 
extended cluster of tuberculosis in homeless men and 
their associates. J Znf Dis 1993; 167: 49&494. 
8. Small PM, Shafer RW, Hopewell PC et al. Exogenous 
reinfection with multi-drug resistant Mycobacterium 
tuberculosis in patients with advanced HIV infection, 
NEnglJMed1993;328: 1137-1144. 
9. Genewein A, Telenti A, Bernasconi C et al. Molecular 
approach to identifying routes of transmission of 
tuberculosis in the community. Lancet 1993; 342: 
841-844. 
